A Study to Evaluate Virtual Reality As Adjunct to Anesthesia During Orthopedic Surgery

Use of Virtual Reality as an Adjunct for Anesthesia During Orthopedic Procedures Under Regional or Central Neuraxial Nerve Block. A Pilot and Feasibility Study

Status

Enrolling by invitation

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05112302

Enrollment

Registered

2021-11-08

Start date

2021-08-17

Completion date

2026-12-01

Last updated

2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Injuries, Knee Arthropathy

Keywords

virtual reality, knee arthroplasty, hip arthroplasty

Brief summary

The purpose of this study is to obtain feedback from patients and orthopedic surgeons who agree to use virtual reality (VR ) as an adjunct to standard of care in orthopedic cases under regional or central neuraxial nerve block. This will serve as a preliminary study for future trials to compare outcomes between VR and standard of care vs standard of care only.

Interventions

OTHERVirtual reality

Use of virtual reality goggles during procedure

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age ≥ 18 years old. * Patients scheduled for orthopedic procedure under regional or central neuraxial nerve block (anterior primary hip arthroplasty or primary knee arthroplasty). * Subject willing to participate and able to provide informed consent.

Exclusion criteria

* Age \< 18 years old. * History of motion sickness or blindness. * Unable to consent due to cognitive difficulty. * Current diagnosis of epilepsy, dementia, or other neurological disease that may prevent use of VR hardware and software. Sensitivity to flashing light or motion. * Recent stroke. * Injury to the eyes, face, neck, or arms that prevents comfortable use of VR hardware or software, or safe use of the hardware (e.g., open wound, sores, or skin rash on face).

Design outcomes

Primary

Measure	Time frame	Description
Impact of virtual reality on anxiety level	Up to 2 hours	Evaluate patients' satisfaction with using virutal reality and reduction in anxiety during orthopedic procedures

Secondary

Measure	Time frame	Description
Impact of virtual reality on pharmacological therapy doses	Up to 2 hours	Elucidate the impact of VR on pharmacological therapy doses required for proper analgesia and anxiolysis and on reduction of drug side effects in patient using VR during surgeries.
Impact of virtual reality on patient's perioperative temperature	Up to 3 hours	Evaluate if utilizing virtual reality has a positive impact in preventing patient hypothermia intra- and post-operatively.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKlaus Torp, MD

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026